CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

BSE 532039 ZENOTECH INE486F01012
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

7 filings · 2 material · busiest 2026-07-28

What it files

Newspaper Publication2 Results1 Board Outcome1 Compliance Certificate1 Board Meeting1 Trading Window1

Filings

7 in the window

  1. 24 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement

    Company Update / Newspaper Publication View filing →

  2. 29 July 2026

    Newspaper Publication

    Newspaper Publication

    Publication of extract of Unaudited Financial Results for the quarter ended June 30, 2026 in newspapers.

    Company Update / Newspaper Publication View filing →

  3. 28 July 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Submission of Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

    Result / Financial Results View filing →

  4. 28 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held Today, I.E., July 28, 2026

    Outcome of the Board Meeting held today, i.e., July 28, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  5. 14 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 13 July 2026

    Board Meeting

    Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026.

    Zenotech Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....

    Board Meeting / Board Meeting View filing →

  7. 30 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →